![](https://www.diabetesnews.com/wp-content/uploads/2012/04/Glucagon-Primary-antibodies-ab10988-11-150x150.jpg)
“We want to make it easy for everyone to be able to help anyone who uses insulin anywhere, anytime,” says Locemia co-creator and chairman Robert Oringer, an entrepreneur with a long history in the diabetes industry.
“We want to make it easy for everyone to be able to help anyone who uses insulin anywhere, anytime,” says Locemia co-creator and chairman Robert Oringer, an entrepreneur with a long history in the diabetes industry.